Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 4.

Jelinek, Tomas (2018). What is verified for travel vaccinations? Internist, 59 (12). S. 1255 - 1268. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1289

Jelinek, Tomas, Cromer, Michael A., Cramer, Jakob P., Mills, Deborah J., Lessans, Kenneth, Gherardin, Anthony W., Barnett, Elizabeth D., Hagmann, Stefan H. F., Askling, Helena H., Kiermayr, Sigrid, Kadlecek, Vera, Eder-Lingelbach, Susanne, Taucher, Christian and Dubischar, Katrin L. (2018). Safety and immunogenicity of an inactivated Vero cell_derived Japanese encephalitis vaccine (IXIARO (R), JESPECT (R)) in a pediatric population in JE non-endemic countries: An uncontrolled, open-label phase 3 study. Travel Med. Infect. Dis., 22. S. 18 - 25. OXFORD: ELSEVIER SCI LTD. ISSN 1873-0442

Schwameis, Michael, Kundig, Thomas, Huber, Gustave, von Bidder, Luzi, Meinel, Lorenz ORCID: 0000-0002-7549-7627, Weisser, Roland, Aberer, Elisabeth, Haerter, Georg, Weinke, Thomas, Jelinek, Tomas, Faekenheuer, Gerd, Wollina, Uwe ORCID: 0000-0001-5933-2913, Burchard, Gerd-Dieter, Aschoff, Roland, Nischik, Ruth, Sattler, Gerhard, Popp, Georg, Lotte, Wolfgang, Wiechert, Dirk, Eder, Gerald, Maus, Olga, Staubach-Renz, Petra, Graefe, Andrea, Geigenberger, Veronika, Naudts, Ingomar, Sebastian, Michael, Reider, Norbert, Weber, Ridwan, Heckmann, Marc, Reisinger, Emil C., Klein, Georg, Wantzen, Johannes and Jilma, Bernd (2017). Topical azithromycin for the prevention of Lyme borreliosis: a randomised, placebo-controlled, phase 3 efficacy trial. Lancet Infect. Dis., 17 (3). S. 322 - 330. OXFORD: ELSEVIER SCI LTD. ISSN 1474-4457

Taucher, Christian, Barnett, Elizabeth D., Cramer, Jakob P., Eder-Lingelbach, Susanne, Jelinek, Tomas, Kadlecek, Vera, Kiermayr, Sigrid, Mills, Deborah J., Pandis, Duellyn, Reiner, Daniela and Dubischar, Katrin L. (2020). Neutralizing antibody persistence in pediatric travelers from non-JE-endemic countries following vaccination with IXIARO (R) Japanese encephalitis vaccine: An uncontrolled, open-label phase 3 follow-up study. Travel Med. Infect. Dis., 34. OXFORD: ELSEVIER SCI LTD. ISSN 1873-0442

This list was generated on Tue Jun 15 06:13:02 2021 CEST.